Header Logo

Sonal Singh

Concepts (661)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pulmonary Disease, Chronic Obstructive
15
2014
240
4.280
Why?
Hypoglycemic Agents
15
2021
187
4.130
Why?
Diabetes Mellitus, Type 2
19
2018
617
3.820
Why?
Cough
13
2021
160
3.800
Why?
Thiazolidinediones
10
2015
45
3.290
Why?
Cardiovascular Diseases
16
2021
671
3.130
Why?
Scopolamine Derivatives
9
2014
10
2.810
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8
2019
185
2.330
Why?
Warfare
12
2014
29
2.330
Why?
Humans
179
2023
50087
2.280
Why?
Gastrointestinal Hemorrhage
5
2020
74
2.260
Why?
Cholinergic Antagonists
6
2014
25
2.180
Why?
Pancreatitis
7
2015
76
2.140
Why?
Randomized Controlled Trials as Topic
24
2020
477
2.050
Why?
Drug-Related Side Effects and Adverse Reactions
6
2021
130
1.960
Why?
Drugs, Generic
3
2018
17
1.950
Why?
Decision Support Techniques
5
2020
151
1.610
Why?
Delivery of Health Care
7
2021
339
1.590
Why?
Adverse Drug Reaction Reporting Systems
4
2017
44
1.570
Why?
Dabigatran
4
2020
18
1.550
Why?
Adrenal Cortex Hormones
5
2018
101
1.490
Why?
Pneumonia
6
2018
226
1.440
Why?
Anticoagulants
9
2015
385
1.420
Why?
Benzazepines
3
2012
18
1.300
Why?
Research Design
11
2023
531
1.290
Why?
Quinoxalines
3
2012
34
1.260
Why?
Bronchodilator Agents
4
2014
49
1.260
Why?
Myocardial Infarction
9
2018
809
1.250
Why?
Myocardial Ischemia
3
2014
89
1.250
Why?
United States Food and Drug Administration
5
2018
82
1.240
Why?
Aortic Aneurysm
2
2018
73
1.230
Why?
Clinical Trials as Topic
9
2018
364
1.230
Why?
Administration, Inhalation
12
2014
78
1.190
Why?
Alzheimer Disease
2
2021
401
1.170
Why?
Evidence-Based Medicine
8
2019
360
1.170
Why?
Risk Assessment
19
2020
1550
1.120
Why?
Warfarin
6
2015
88
1.090
Why?
Male
52
2023
22850
1.070
Why?
Renal Insufficiency
2
2023
46
1.060
Why?
Atrial Fibrillation
5
2015
544
1.050
Why?
Glucagon-Like Peptide 1
3
2018
13
1.020
Why?
Female
58
2022
26107
1.020
Why?
Anti-Bacterial Agents
4
2018
584
1.000
Why?
Algorithms
5
2020
869
1.000
Why?
Aged
35
2023
10736
0.990
Why?
Ipratropium
3
2014
7
0.980
Why?
Asthma
2
2022
366
0.970
Why?
Human Rights
5
2008
14
0.970
Why?
Nicotinic Agonists
3
2012
40
0.950
Why?
Primary Prevention
3
2019
116
0.930
Why?
Heart Failure
7
2016
647
0.920
Why?
Cardiovascular System
2
2021
32
0.910
Why?
Periodicals as Topic
2
2020
159
0.900
Why?
Anti-Asthmatic Agents
1
2022
38
0.890
Why?
Renal Insufficiency, Chronic
1
2023
83
0.880
Why?
Death, Sudden, Cardiac
2
2019
54
0.870
Why?
Prescription Drugs
3
2018
45
0.870
Why?
Review Literature as Topic
5
2016
36
0.850
Why?
Biological Products
1
2022
66
0.850
Why?
Adult
32
2023
13130
0.830
Why?
Antiparkinson Agents
1
2021
6
0.820
Why?
Dopamine Antagonists
1
2021
14
0.820
Why?
Fluoroquinolones
2
2018
19
0.810
Why?
Middle Aged
36
2021
13228
0.790
Why?
Treatment Outcome
17
2023
3878
0.780
Why?
Hospitalization
5
2022
1075
0.780
Why?
Public Health
3
2007
152
0.780
Why?
Practice Guidelines as Topic
6
2018
569
0.780
Why?
HIV Infections
9
2017
888
0.780
Why?
Nepal
13
2016
87
0.770
Why?
Risk Factors
20
2018
4246
0.760
Why?
Tiotropium Bromide
8
2014
9
0.760
Why?
Intracranial Hemorrhages
1
2020
38
0.760
Why?
Vaccination Coverage
1
2019
6
0.750
Why?
Pharmaceutical Preparations
1
2021
114
0.750
Why?
Wernicke Encephalopathy
4
2007
4
0.740
Why?
Testosterone
2
2016
121
0.730
Why?
Drug Prescriptions
1
2021
174
0.720
Why?
Myocarditis
1
2019
27
0.710
Why?
Glucocorticoids
2
2011
126
0.710
Why?
Human Rights Abuses
3
2007
3
0.700
Why?
United States
18
2023
6224
0.700
Why?
Urinary Bladder Neoplasms
2
2015
42
0.690
Why?
beta-Alanine
2
2015
9
0.690
Why?
Refugees
4
2008
53
0.690
Why?
Databases, Factual
5
2021
710
0.690
Why?
Decision Making
3
2018
315
0.680
Why?
Immunologic Factors
1
2019
93
0.680
Why?
Cause of Death
3
2019
170
0.680
Why?
Thiophenes
2
2015
33
0.680
Why?
Morpholines
2
2015
61
0.680
Why?
Early Detection of Cancer
1
2020
194
0.680
Why?
Antibodies, Monoclonal, Humanized
1
2020
172
0.680
Why?
Patient Participation
1
2020
184
0.670
Why?
Benzimidazoles
2
2015
48
0.660
Why?
Statistics as Topic
1
2018
136
0.660
Why?
Amphetamine
1
2017
10
0.640
Why?
Herpes Zoster
1
2017
20
0.640
Why?
Thyroxine
1
2017
48
0.630
Why?
Incidence
9
2022
1093
0.630
Why?
Guidelines as Topic
4
2012
142
0.620
Why?
Cerebrovascular Disorders
1
2017
60
0.620
Why?
Incretins
1
2016
5
0.620
Why?
Lung Neoplasms
2
2020
447
0.620
Why?
Atherosclerosis
1
2018
135
0.610
Why?
Antithrombins
1
2017
13
0.610
Why?
Disasters
2
2014
20
0.610
Why?
Health Services Accessibility
6
2009
443
0.590
Why?
Bronchitis
2
2020
23
0.570
Why?
Arrhythmias, Cardiac
2
2016
99
0.570
Why?
Pharyngitis
2
2006
11
0.570
Why?
Stroke
5
2017
874
0.570
Why?
Streptococcus pyogenes
2
2006
24
0.560
Why?
Rhabdomyolysis
2
2006
22
0.550
Why?
Fluorobenzenes
2
2005
4
0.550
Why?
Streptococcal Infections
2
2006
68
0.550
Why?
Fractures, Bone
3
2011
130
0.540
Why?
Pharmacoepidemiology
1
2014
12
0.540
Why?
Vena Cava Filters
2
2014
19
0.530
Why?
Risk
7
2020
349
0.530
Why?
Heptanoic Acids
2
2004
18
0.530
Why?
Aged, 80 and over
12
2021
4109
0.520
Why?
Pyrroles
2
2004
44
0.520
Why?
Pyrimidines
2
2005
96
0.520
Why?
Sulfonamides
2
2005
110
0.510
Why?
Tomography, X-Ray Computed
1
2020
1044
0.510
Why?
Developing Countries
4
2008
71
0.500
Why?
Bariatric Surgery
3
2013
32
0.500
Why?
Embolism, Paradoxical
1
2014
10
0.500
Why?
Medication Adherence
2
2015
254
0.490
Why?
Urinary Retention
2
2011
25
0.490
Why?
Azasteroids
1
2013
2
0.490
Why?
5-alpha Reductase Inhibitors
1
2013
2
0.490
Why?
Consensus
3
2018
130
0.490
Why?
Valproic Acid
1
2013
19
0.490
Why?
Health Planning Guidelines
1
2013
26
0.480
Why?
Age Factors
8
2021
1374
0.480
Why?
Relief Work
3
2007
12
0.480
Why?
Dose-Response Relationship, Drug
6
2014
708
0.470
Why?
Anticonvulsants
1
2013
85
0.470
Why?
Biomedical Research
3
2013
225
0.470
Why?
Meta-Analysis as Topic
5
2015
69
0.470
Why?
Child Development Disorders, Pervasive
1
2013
50
0.470
Why?
Prostatic Neoplasms
1
2015
298
0.460
Why?
Insulin
1
2016
646
0.450
Why?
Diagnostic Techniques and Procedures
1
2012
8
0.450
Why?
Cohort Studies
5
2021
2047
0.450
Why?
Epilepsy
1
2013
90
0.450
Why?
Pancreatic Neoplasms
1
2015
267
0.450
Why?
Macular Edema
1
2012
21
0.440
Why?
Tobacco Use Cessation
1
2012
31
0.440
Why?
Acute Disease
6
2020
579
0.440
Why?
Chronic Disease
6
2021
650
0.430
Why?
Bupropion
1
2011
8
0.430
Why?
Prenatal Exposure Delayed Effects
1
2013
153
0.430
Why?
Diabetic Angiopathies
2
2008
28
0.420
Why?
Wounds and Injuries
1
2014
203
0.420
Why?
Mucociliary Clearance
1
2021
5
0.420
Why?
Reflex
1
2021
25
0.420
Why?
Venoms
3
2016
10
0.410
Why?
Opportunistic Infections
1
2011
26
0.410
Why?
Dipeptidyl-Peptidase IV Inhibitors
4
2021
7
0.410
Why?
Autistic Disorder
1
2013
147
0.410
Why?
Quality of Life
3
2020
770
0.410
Why?
Nicotine
1
2011
120
0.390
Why?
Lower Extremity
3
2021
117
0.390
Why?
Respiratory Tract Infections
1
2011
67
0.390
Why?
Product Surveillance, Postmarketing
4
2012
17
0.390
Why?
Suicide
1
2011
97
0.390
Why?
Bronchitis, Chronic
1
2020
5
0.390
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2011
162
0.390
Why?
Child
11
2020
3788
0.380
Why?
Eosinophilia
1
2020
24
0.380
Why?
Retrospective Studies
9
2022
4549
0.380
Why?
Postoperative Complications
4
2013
868
0.370
Why?
Outpatients
2
2020
116
0.370
Why?
Kidney Failure, Chronic
2
2008
158
0.370
Why?
Mortality
3
2018
136
0.370
Why?
Hypertension
2
2021
533
0.360
Why?
Glucagon-Like Peptide-1 Receptor
2
2021
11
0.360
Why?
International Cooperation
5
2008
78
0.360
Why?
Observational Studies as Topic
3
2019
30
0.360
Why?
Administration, Oral
4
2015
289
0.360
Why?
Depression
3
2014
751
0.360
Why?
Diphosphonates
1
2009
30
0.350
Why?
Outsourced Services
1
2008
3
0.350
Why?
Health
2
2006
33
0.350
Why?
Whooping Cough
1
2018
15
0.350
Why?
Gastroesophageal Reflux
1
2019
62
0.350
Why?
Bone Density Conservation Agents
1
2009
45
0.350
Why?
Polyethylene Glycols
2
2023
158
0.350
Why?
Publication Bias
4
2012
12
0.350
Why?
Emigration and Immigration
2
2008
22
0.340
Why?
Bronchiolitis, Viral
1
2018
4
0.340
Why?
Disaster Planning
3
2015
34
0.340
Why?
Pregnancy Complications
1
2013
373
0.340
Why?
Adolescent
9
2020
5244
0.340
Why?
Patient Education as Topic
2
2011
436
0.340
Why?
Stomatitis
1
2008
3
0.340
Why?
Lung Diseases, Interstitial
1
2018
34
0.330
Why?
Simvastatin
2
2005
26
0.330
Why?
Antiviral Agents
2
2023
294
0.330
Why?
Attitude to Health
2
2008
283
0.330
Why?
Secondary Prevention
2
2019
128
0.330
Why?
Interferon-alpha
1
2008
92
0.320
Why?
Patient Advocacy
1
2007
23
0.320
Why?
Civil Disorders
1
2007
2
0.320
Why?
Critical Illness
1
2020
251
0.320
Why?
Peptides
3
2016
489
0.320
Why?
Young Adult
7
2021
3679
0.310
Why?
Lisinopril
1
2006
4
0.310
Why?
Contrast Media
2
2008
294
0.310
Why?
Mass Screening
2
2017
538
0.310
Why?
Child Welfare
2
2009
48
0.310
Why?
Renal Dialysis
1
2008
167
0.300
Why?
Sample Size
4
2023
56
0.300
Why?
Tuberculosis, Pulmonary
1
2017
91
0.300
Why?
Amiodarone
1
2006
10
0.290
Why?
Information Dissemination
1
2007
107
0.290
Why?
Clinical Clerkship
1
2006
76
0.290
Why?
Pulmonary Alveoli
1
2006
42
0.290
Why?
Hydralazine
1
2006
1
0.290
Why?
Anti-Arrhythmia Agents
1
2006
28
0.290
Why?
Smoking Cessation
1
2011
548
0.290
Why?
Influenza, Human
1
2018
191
0.290
Why?
Vasoconstrictor Agents
1
2006
31
0.290
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2006
133
0.290
Why?
Self Care
1
2008
209
0.290
Why?
Vasodilator Agents
1
2006
43
0.280
Why?
Internal Medicine
1
2006
137
0.280
Why?
Patient Selection
5
2015
345
0.280
Why?
Hemorrhage
2
2008
224
0.280
Why?
Religion and Medicine
1
2005
21
0.280
Why?
Myelography
1
2005
1
0.280
Why?
Iopamidol
1
2005
13
0.280
Why?
Carotid Stenosis
1
2006
83
0.280
Why?
Cocaine-Related Disorders
1
2006
67
0.280
Why?
Religion
1
2005
27
0.270
Why?
Kidney Transplantation
1
2006
181
0.270
Why?
Bariatrics
1
2005
1
0.270
Why?
Aging
1
2021
676
0.270
Why?
Cocaine
1
2006
83
0.270
Why?
Aminopyridines
2
2016
19
0.270
Why?
Pharynx
1
2005
19
0.270
Why?
Societies, Medical
1
2006
217
0.270
Why?
Benzamides
2
2016
45
0.270
Why?
Patient-Centered Care
2
2019
219
0.270
Why?
Disease Outbreaks
1
2005
94
0.270
Why?
Formularies as Topic
1
2004
2
0.270
Why?
Lung Diseases
1
2006
121
0.270
Why?
Community Health Services
1
2006
125
0.270
Why?
Follow-Up Studies
4
2018
1910
0.270
Why?
Referral and Consultation
1
2008
344
0.260
Why?
Peripheral Nervous System Diseases
1
2005
28
0.260
Why?
Lupus Erythematosus, Systemic
1
2006
125
0.260
Why?
Healthcare Disparities
1
2008
255
0.260
Why?
Social Justice
1
2004
24
0.260
Why?
Seizures
1
2005
92
0.260
Why?
Acute Kidney Injury
1
2006
103
0.260
Why?
Antipsychotic Agents
2
2015
271
0.260
Why?
Drug Therapy, Combination
5
2018
349
0.250
Why?
Heart Transplantation
1
2004
68
0.250
Why?
Drug Administration Schedule
3
2014
241
0.250
Why?
Bias
3
2014
97
0.250
Why?
Health Services
1
2004
84
0.250
Why?
Obesity
2
2013
1114
0.240
Why?
Health Knowledge, Attitudes, Practice
2
2009
697
0.240
Why?
Tenofovir
1
2023
18
0.240
Why?
Intracranial Aneurysm
1
2006
198
0.240
Why?
Adenine
1
2023
38
0.240
Why?
Physicians
3
2022
387
0.240
Why?
Socioeconomic Factors
5
2016
740
0.240
Why?
Child Abuse
1
2004
81
0.240
Why?
Military Personnel
1
2004
79
0.240
Why?
Blood Glucose
3
2018
443
0.230
Why?
Health Expenditures
1
2004
91
0.230
Why?
Dementia
1
2005
184
0.230
Why?
Acquired Immunodeficiency Syndrome
3
2009
123
0.230
Why?
Ivermectin
1
2022
7
0.220
Why?
Reproducibility of Results
3
2017
1291
0.220
Why?
Kidney
2
2023
345
0.220
Why?
Basophils
1
2021
15
0.220
Why?
Influenza Vaccines
1
2023
92
0.220
Why?
Varenicline
2
2011
9
0.220
Why?
Staphylococcal Skin Infections
1
2021
13
0.220
Why?
Pilot Projects
3
2017
755
0.210
Why?
Interleukin-4
1
2021
121
0.210
Why?
Double-Blind Method
3
2023
540
0.210
Why?
International Classification of Diseases
2
2019
128
0.210
Why?
Venous Thromboembolism
2
2013
139
0.210
Why?
Delphi Technique
3
2019
63
0.210
Why?
Medication Systems
1
2021
18
0.210
Why?
Diuretics
1
2021
52
0.200
Why?
Calcium Channel Blockers
1
2021
49
0.200
Why?
Pharmacy
1
2021
14
0.200
Why?
Data Collection
2
2019
359
0.200
Why?
Severity of Illness Index
2
2020
1155
0.200
Why?
Ambulatory Care
3
2023
259
0.200
Why?
Case-Control Studies
3
2013
909
0.200
Why?
Staphylococcal Infections
1
2021
94
0.200
Why?
Polypharmacy
1
2021
57
0.200
Why?
Proton Pump Inhibitors
2
2019
28
0.200
Why?
Anti-Infective Agents
1
2022
105
0.200
Why?
Safety Management
2
2012
129
0.200
Why?
Vaccines
1
2021
81
0.190
Why?
Peripheral Arterial Disease
2
2020
124
0.190
Why?
Medication Errors
1
2021
110
0.190
Why?
Vaccination
4
2023
286
0.190
Why?
Prevalence
5
2013
1101
0.190
Why?
Drug Labeling
2
2012
29
0.190
Why?
Antihypertensive Agents
1
2021
154
0.190
Why?
Pharmacists
1
2021
103
0.190
Why?
Prognosis
3
2014
1215
0.190
Why?
Electronic Health Records
2
2019
275
0.190
Why?
Patient Safety
2
2012
188
0.190
Why?
Death Certificates
1
2019
8
0.190
Why?
Medicare
1
2023
465
0.180
Why?
Vulnerable Populations
2
2013
76
0.180
Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
31
0.180
Why?
Canagliflozin
1
2018
2
0.180
Why?
Reminder Systems
1
2019
71
0.170
Why?
Health Status
2
2016
401
0.170
Why?
Rivaroxaban
2
2015
13
0.170
Why?
Armed Conflicts
1
2018
2
0.170
Why?
Exposure to Violence
1
2018
3
0.170
Why?
Health Facilities
1
2018
29
0.170
Why?
Comparative Effectiveness Research
3
2013
34
0.170
Why?
Data Interpretation, Statistical
3
2015
186
0.170
Why?
Education
1
2018
68
0.170
Why?
Osteoporotic Fractures
1
2018
31
0.170
Why?
Quality Control
1
2018
63
0.170
Why?
Multiple Chronic Conditions
1
2018
32
0.170
Why?
Cooperative Behavior
1
2019
200
0.160
Why?
Communication
2
2019
449
0.160
Why?
Budesonide
2
2023
10
0.160
Why?
Respiratory Function Tests
2
2009
103
0.160
Why?
Health Education
1
2019
188
0.160
Why?
Herpes Zoster Ophthalmicus
1
2017
6
0.160
Why?
Metformin
2
2015
56
0.160
Why?
Torture
2
2008
2
0.160
Why?
Crime Victims
1
2018
37
0.160
Why?
Practice Patterns, Physicians'
2
2021
658
0.160
Why?
Stress, Psychological
2
2014
384
0.160
Why?
Population Surveillance
1
2018
198
0.160
Why?
Insulin Detemir
1
2016
1
0.160
Why?
Glucagon-Like Peptides
1
2016
1
0.160
Why?
Insulin Glargine
1
2016
2
0.160
Why?
Cross-Sectional Studies
3
2019
2133
0.160
Why?
Insulin, Long-Acting
1
2016
2
0.160
Why?
Liraglutide
1
2016
2
0.160
Why?
Observer Variation
1
2017
172
0.160
Why?
Medical Records
1
2017
130
0.150
Why?
Registries
1
2019
641
0.150
Why?
Hormone Replacement Therapy
1
2016
32
0.150
Why?
China
2
2008
108
0.150
Why?
Thiamine Deficiency
2
2007
5
0.150
Why?
Androgens
1
2016
53
0.150
Why?
Immunoglobulin Fc Fragments
1
2016
45
0.150
Why?
Antiretroviral Therapy, Highly Active
2
2006
95
0.150
Why?
Drug Evaluation
1
2016
18
0.150
Why?
Widowhood
1
2016
4
0.150
Why?
Hypoglycemia
1
2016
61
0.150
Why?
Surge Capacity
1
2015
2
0.140
Why?
Hospital Mortality
1
2020
701
0.140
Why?
Social Isolation
1
2016
24
0.140
Why?
Drug Interactions
2
2007
103
0.140
Why?
Research
2
2015
182
0.140
Why?
Cognitive Dysfunction
1
2018
187
0.140
Why?
Sensitivity and Specificity
3
2014
934
0.140
Why?
Insurance Claim Review
1
2015
71
0.140
Why?
Checklist
1
2016
55
0.140
Why?
Rosuvastatin Calcium
2
2005
2
0.140
Why?
Comorbidity
1
2018
986
0.140
Why?
Altruism
1
2014
12
0.140
Why?
Adrenomedullin
1
2014
1
0.130
Why?
Multiple Myeloma
1
2019
263
0.130
Why?
Recombinant Fusion Proteins
1
2016
444
0.130
Why?
Violence
2
2007
149
0.130
Why?
Publishing
1
2016
82
0.130
Why?
Protein Precursors
1
2014
64
0.130
Why?
Health Services Needs and Demand
2
2007
192
0.130
Why?
Aspirin
1
2015
159
0.130
Why?
Health Services Research
1
2015
246
0.130
Why?
Phosphodiesterase 4 Inhibitors
1
2013
1
0.130
Why?
Patient Compliance
2
2006
320
0.130
Why?
Bibliometrics
1
2013
24
0.120
Why?
Time Factors
3
2011
3106
0.120
Why?
Dutasteride
1
2013
1
0.120
Why?
Pakistan
1
2013
8
0.120
Why?
Prostatic Diseases
1
2013
6
0.120
Why?
Sex Workers
1
2013
6
0.120
Why?
Publications
1
2013
23
0.120
Why?
Prospective Studies
2
2017
2524
0.120
Why?
Emergency Medicine
1
2015
151
0.120
Why?
Sitagliptin Phosphate
1
2013
2
0.120
Why?
Meditation
1
2014
54
0.120
Why?
Bone Density
2
2018
161
0.120
Why?
Diabetes Mellitus
1
2018
506
0.120
Why?
Tetrabenazine
1
2013
1
0.120
Why?
Affect
1
2014
115
0.120
Why?
Adrenergic Uptake Inhibitors
1
2013
13
0.120
Why?
Drug Recalls
1
2012
1
0.120
Why?
Triazoles
1
2013
52
0.120
Why?
Social Support
1
2016
335
0.120
Why?
Pyrazines
1
2013
28
0.120
Why?
Substance Abuse, Intravenous
1
2013
58
0.120
Why?
Therapeutic Equivalency
1
2012
9
0.110
Why?
Endpoint Determination
1
2012
22
0.110
Why?
Risk Reduction Behavior
1
2013
125
0.110
Why?
Histamine H2 Antagonists
1
2012
8
0.110
Why?
Neoplasms
2
2015
1049
0.110
Why?
Bayes Theorem
2
2023
96
0.110
Why?
Emergency Service, Hospital
1
2019
795
0.110
Why?
Enterocolitis, Pseudomembranous
1
2012
28
0.110
Why?
Suicidal Ideation
1
2013
81
0.110
Why?
MP3-Player
1
2011
2
0.110
Why?
Platelet Aggregation Inhibitors
1
2013
183
0.110
Why?
Androstadienes
1
2011
14
0.110
Why?
Fluticasone
1
2011
5
0.110
Why?
Huntington Disease
1
2013
128
0.100
Why?
Mental Disorders
2
2009
655
0.100
Why?
Neuromuscular Diseases
1
2021
18
0.100
Why?
Survival Analysis
1
2012
460
0.100
Why?
Health Care Rationing
2
2015
19
0.100
Why?
Salmeterol Xinafoate
1
2010
2
0.100
Why?
Observation
1
2010
21
0.100
Why?
Albuterol
1
2010
15
0.100
Why?
Patient Satisfaction
2
2011
357
0.100
Why?
Reference Values
1
2011
301
0.100
Why?
Symptom Flare Up
1
2020
11
0.100
Why?
Biomechanical Phenomena
1
2021
228
0.100
Why?
Symptom Assessment
1
2020
38
0.100
Why?
Needs Assessment
2
2015
158
0.090
Why?
Quality Indicators, Health Care
1
2012
304
0.090
Why?
Technology, Pharmaceutical
1
2009
20
0.090
Why?
Logistic Models
1
2013
1138
0.090
Why?
Respiratory Aspiration
1
2009
4
0.090
Why?
Anti-Retroviral Agents
1
2009
72
0.090
Why?
Program Evaluation
2
2011
458
0.090
Why?
Sodium Bicarbonate
1
2008
11
0.090
Why?
Bronchoscopy
1
2009
50
0.090
Why?
Latin America
1
2008
12
0.090
Why?
Foreign Bodies
1
2009
34
0.090
Why?
Africa
1
2008
17
0.090
Why?
Drug Discovery
1
2009
75
0.090
Why?
Japan
1
2008
43
0.090
Why?
Russia
1
2008
46
0.090
Why?
Colorectal Neoplasms
1
2011
206
0.090
Why?
Taiwan
2
2021
7
0.090
Why?
Sarcoidosis, Pulmonary
1
2018
8
0.090
Why?
Scleroderma, Systemic
1
2018
11
0.090
Why?
Thiamine
2
2007
18
0.090
Why?
Tibet
2
2006
3
0.090
Why?
Research Support as Topic
1
2008
38
0.090
Why?
Government Regulation
1
2008
40
0.090
Why?
Sex Factors
1
2021
834
0.090
Why?
Drug Industry
1
2008
39
0.090
Why?
Recurrence
2
2012
481
0.080
Why?
Odds Ratio
2
2008
743
0.080
Why?
India
1
2008
141
0.080
Why?
Kidney Function Tests
1
2008
30
0.080
Why?
Health Personnel
2
2018
313
0.080
Why?
Nephrology
1
2008
13
0.080
Why?
Sulfonylurea Compounds
2
2020
14
0.080
Why?
Anti-HIV Agents
2
2006
169
0.080
Why?
Cardiac Output, Low
1
2007
8
0.080
Why?
Causality
1
2008
56
0.080
Why?
Postgastrectomy Syndromes
1
2007
3
0.080
Why?
Rwanda
1
2007
11
0.080
Why?
Malabsorption Syndromes
1
2007
4
0.080
Why?
Anecdotes as Topic
1
2007
9
0.080
Why?
Osteoporosis
1
2009
121
0.080
Why?
Public Policy
1
2008
27
0.080
Why?
Toxins, Biological
1
2007
6
0.080
Why?
Patient Care Planning
1
2008
67
0.080
Why?
Homicide
1
2007
20
0.080
Why?
New York City
1
2007
70
0.080
Why?
Child, Preschool
2
2020
1664
0.080
Why?
Catheters, Indwelling
1
2008
58
0.080
Why?
Anxiety
2
2014
334
0.080
Why?
Health Policy
2
2008
161
0.080
Why?
Kidney Diseases
1
2008
143
0.080
Why?
Homosexuality, Male
1
2007
55
0.080
Why?
Communicable Disease Control
1
2007
36
0.080
Why?
Internet
1
2011
460
0.080
Why?
Catheterization, Central Venous
1
2008
77
0.080
Why?
Theft
1
2006
3
0.080
Why?
Biomarkers
2
2014
978
0.080
Why?
Developed Countries
1
2006
10
0.080
Why?
Disease Susceptibility
1
2007
126
0.080
Why?
Safety
1
2007
126
0.080
Why?
Educational Status
1
2008
266
0.080
Why?
Minority Groups
1
2008
114
0.080
Why?
Communicable Diseases
1
2007
75
0.080
Why?
History, 21st Century
1
2007
138
0.080
Why?
Vascular Neoplasms
1
2006
12
0.080
Why?
Police
1
2006
30
0.070
Why?
Infant Mortality
1
2006
20
0.070
Why?
HIV
1
2006
74
0.070
Why?
Guideline Adherence
1
2008
259
0.070
Why?
Expert Systems
1
2006
6
0.070
Why?
Life Change Events
1
2006
67
0.070
Why?
Penicillins
1
2006
24
0.070
Why?
History, 20th Century
1
2007
216
0.070
Why?
Pregnancy
1
2013
2108
0.070
Why?
Vasoconstriction
1
2006
14
0.070
Why?
Likelihood Functions
1
2006
68
0.070
Why?
Ethics, Research
1
2006
19
0.070
Why?
Lymphoma, Large B-Cell, Diffuse
1
2006
52
0.070
Why?
Endarterectomy, Carotid
1
2006
68
0.070
Why?
Tachycardia, Ventricular
1
2006
41
0.070
Why?
Thrombosis
1
2008
170
0.070
Why?
Recombinant Proteins
1
2008
627
0.070
Why?
AIDS Vaccines
1
2006
64
0.070
Why?
Decision Support Systems, Clinical
1
2006
63
0.070
Why?
Maternal Health Services
1
2006
57
0.070
Why?
Educational Measurement
1
2006
176
0.070
Why?
Condoms
1
2005
46
0.070
Why?
Child Health Services
1
2006
57
0.070
Why?
Patient Care Team
1
2008
264
0.070
Why?
Diabetic Nephropathies
1
2005
37
0.070
Why?
Horner Syndrome
1
2005
2
0.070
Why?
Communism
1
2004
1
0.070
Why?
Carotid Artery, Internal, Dissection
1
2005
6
0.070
Why?
War Crimes
1
2004
2
0.070
Why?
Nutrition Disorders
1
2004
7
0.070
Why?
Principle-Based Ethics
1
2004
2
0.070
Why?
Cyclopropanes
2
2016
33
0.070
Why?
Infant
2
2006
1394
0.070
Why?
Poverty
1
2007
278
0.070
Why?
Psychology, Child
1
2004
6
0.070
Why?
Family Practice
1
2006
176
0.070
Why?
Resource Allocation
1
2004
18
0.070
Why?
Rural Health
1
2004
17
0.070
Why?
Health Planning
1
2004
23
0.070
Why?
Malaria, Vivax
1
2005
32
0.070
Why?
Total Quality Management
1
2004
47
0.070
Why?
Cyclosporine
1
2004
48
0.070
Why?
Child Advocacy
1
2004
6
0.060
Why?
Massachusetts
2
2021
1962
0.060
Why?
Embolization, Therapeutic
1
2006
161
0.060
Why?
Education, Medical
1
2006
165
0.060
Why?
Drug Utilization
1
2006
212
0.060
Why?
Morbidity
1
2004
92
0.060
Why?
Drug Delivery Systems
1
2008
273
0.060
Why?
Postoperative Care
1
2004
88
0.060
Why?
Medicaid
2
2019
299
0.060
Why?
Gastric Bypass
1
2004
65
0.060
Why?
Africa South of the Sahara
3
2009
17
0.060
Why?
Students, Medical
1
2006
209
0.060
Why?
Pragmatic Clinical Trials as Topic
1
2023
4
0.060
Why?
Fluvoxamine
1
2023
1
0.060
Why?
Diagnosis, Differential
1
2006
730
0.060
Why?
Stents
1
2006
326
0.060
Why?
Curriculum
1
2006
482
0.060
Why?
Immunosuppressive Agents
1
2004
227
0.060
Why?
Injections, Subcutaneous
1
2023
69
0.060
Why?
Antineoplastic Agents
1
2008
498
0.060
Why?
National Institutes of Health (U.S.)
1
2023
89
0.060
Why?
United States Agency for Healthcare Research and Quality
2
2012
22
0.060
Why?
Intention
1
2022
55
0.060
Why?
Infant, Newborn
1
2006
1165
0.060
Why?
Pharmacogenomic Testing
1
2021
6
0.050
Why?
Peripheral Vascular Diseases
1
2021
42
0.050
Why?
Glucosides
1
2020
9
0.050
Why?
Liver
1
2005
692
0.050
Why?
Clinical Competence
1
2004
547
0.050
Why?
Interviews as Topic
2
2016
408
0.050
Why?
Benzhydryl Compounds
1
2020
40
0.050
Why?
Tennessee
1
2019
10
0.050
Why?
Administrative Claims, Healthcare
1
2019
10
0.050
Why?
Longitudinal Studies
1
2023
1051
0.050
Why?
Genome-Wide Association Study
1
2021
290
0.050
Why?
Qualitative Research
2
2016
433
0.050
Why?
Clinical Coding
1
2019
36
0.050
Why?
Polymorphism, Single Nucleotide
1
2021
408
0.040
Why?
Blood Pressure
1
2021
466
0.040
Why?
United Nations
2
2009
4
0.040
Why?
Government
1
2018
8
0.040
Why?
Bombs
1
2018
3
0.040
Why?
Syria
1
2018
11
0.040
Why?
Epidemiological Monitoring
1
2018
24
0.040
Why?
Propensity Score
1
2018
110
0.040
Why?
Mass Casualty Incidents
1
2018
24
0.040
Why?
Surveys and Questionnaires
2
2018
2272
0.040
Why?
Health Resources
1
2018
69
0.040
Why?
Predictive Value of Tests
1
2019
815
0.040
Why?
Disease Progression
1
2019
733
0.040
Why?
Immunity, Innate
1
2021
695
0.040
Why?
Animals
2
2021
17680
0.040
Why?
Consensus Development Conferences as Topic
1
2015
16
0.040
Why?
Quetiapine Fumarate
1
2015
12
0.040
Why?
Cyclohexanecarboxylic Acids
1
2015
11
0.040
Why?
Selection Bias
1
2015
23
0.040
Why?
Heparin
2
2008
90
0.040
Why?
Neuralgia
1
2015
18
0.040
Why?
Amines
1
2015
29
0.040
Why?
gamma-Aminobutyric Acid
1
2015
67
0.030
Why?
Triage
1
2015
85
0.030
Why?
Analgesics
1
2015
87
0.030
Why?
Adaptation, Psychological
1
2016
228
0.030
Why?
Placebos
1
2013
73
0.030
Why?
Community-Acquired Infections
1
2014
81
0.030
Why?
Emotions
1
2016
187
0.030
Why?
Heparin, Low-Molecular-Weight
1
2013
23
0.030
Why?
Enoxaparin
1
2013
18
0.030
Why?
Proportional Hazards Models
1
2015
619
0.030
Why?
Nasal Sprays
1
2012
2
0.030
Why?
Nebulizers and Vaporizers
1
2012
22
0.030
Why?
Bipolar Disorder
1
2015
242
0.030
Why?
Computer Graphics
1
2012
22
0.030
Why?
Critical Care
1
2015
309
0.030
Why?
International Normalized Ratio
1
2011
35
0.030
Why?
North Carolina
1
2011
42
0.030
Why?
Pulmonary Embolism
1
2013
156
0.030
Why?
Terminology as Topic
1
2012
114
0.030
Why?
Computer-Assisted Instruction
1
2011
68
0.030
Why?
Patient Preference
1
2011
63
0.030
Why?
Health Literacy
1
2011
73
0.020
Why?
Voluntary Health Agencies
1
2009
4
0.020
Why?
Rape
1
2009
12
0.020
Why?
Body Weight
1
2011
381
0.020
Why?
Sodium Chloride
1
2008
52
0.020
Why?
Age Distribution
1
2009
224
0.020
Why?
Lipids
1
2011
287
0.020
Why?
Infusions, Intravenous
1
2008
146
0.020
Why?
Mice
1
2021
9122
0.020
Why?
Sexual Behavior
1
2009
191
0.020
Why?
Bhutan
1
2008
20
0.020
Why?
Elephantiasis, Filarial
1
2007
9
0.020
Why?
Colombia
1
2007
7
0.020
Why?
Myanmar
1
2007
9
0.020
Why?
Yellow Fever
1
2007
3
0.020
Why?
Leishmaniasis, Cutaneous
1
2007
12
0.020
Why?
Half-Life
1
2007
61
0.020
Why?
Thrombocytopenia
1
2008
42
0.020
Why?
Chagas Disease
1
2007
27
0.020
Why?
Hunger
1
2006
14
0.020
Why?
Time
1
2006
24
0.020
Why?
Social Welfare
1
2006
18
0.020
Why?
Leukocyte Common Antigens
1
2006
53
0.020
Why?
North America
1
2006
104
0.020
Why?
Coercion
1
2006
39
0.020
Why?
Lymphoma, B-Cell
1
2006
48
0.020
Why?
Fatal Outcome
1
2006
100
0.020
Why?
Multiple Organ Failure
1
2006
33
0.020
Why?
Clinical Trials Data Monitoring Committees
1
2006
6
0.020
Why?
Cambodia
1
2005
18
0.020
Why?
Confidentiality
1
2006
53
0.020
Why?
Primary Health Care
1
2011
553
0.020
Why?
Prisons
1
2006
81
0.020
Why?
Self-Help Groups
1
2005
40
0.020
Why?
Attitude
1
2006
92
0.020
Why?
Quinine
1
2005
3
0.020
Why?
Informed Consent
1
2006
109
0.020
Why?
Doxycycline
1
2005
33
0.020
Why?
Chloroquine
1
2005
47
0.020
Why?
Drug Resistance, Microbial
1
2005
40
0.020
Why?
Antimalarials
1
2005
64
0.020
Why?
Erythrocytes
1
2005
143
0.020
Why?
Stress Disorders, Post-Traumatic
1
2008
317
0.020
Why?
Singh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (661)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_